| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 474.812 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 567.22 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 595.57 | 93 |
| GSM780719 | Untreated after 4 days (C1_2) | 545.221 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 596.499 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 689.225 | 94 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 836.62 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 592.73 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 562.313 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 785.037 | 94 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 537.635 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 545.063 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 491.247 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 648.859 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 545.53 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 537.437 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 608.108 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 616.516 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 645.695 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 635.23 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 590.552 | 93 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 566.226 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 612.252 | 93 |